» Articles » PMID: 31737358

Clinical Features of Primary and Systemic Metastatic Intraocular Lymphomas in Spanish Patients

Overview
Journal J Ophthalmol
Publisher Wiley
Specialty Ophthalmology
Date 2019 Nov 19
PMID 31737358
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To describe and compare clinical findings in different subtypes of biopsy-proven intraocular lymphomas (IOLs).

Design: Retrospective, observational case series.

Methods: The clinical and pathologic features in IOLs at the Hospital Clinic of Barcelona from 1995 to 2018 were retrospectively studied.

Results: Twenty-one patients, 12 men (57%), median age 60 (interquartile range, IQR: 18 years), and a median follow-up of 30 (IQR 60) months were included. Eleven patients had primary vitreo-retinal lymphoma (PVRL, 52%), 4 had primary uveal lymphoma (PUL, 19%), and 6 had systemic metastatic retinal lymphomas (SMRLs, 28%). Diffuse large B-cell lymphoma was the main IOL subset in PVRL (91%) and in SMRL (83%), whereas extranodal marginal zone lymphoma was the only type in PUL (100%). Survival rate was 44% in PVRL and 20% in SMRL at 5 years (=0.047). One patient had flow cytometry of two different vitreous humour samples. With them, flow cytometry was performed in a total of 11 samples, yielding 7 positive samples.

Conclusions And Relevance: Even though PVRL is the most frequent IOL subtype, our findings suggest that PUL and SMRL should be considered as potential IOL causes. Overall survival was poor in PVRL and even shorter in SMRL patients.

Citing Articles

Bilateral optic disc edema and serous retinal detachment as initial ocular manifestations of systemic lymphoma: A case report and literature review.

Wu C, Chen C, Liou S, Yen J Taiwan J Ophthalmol. 2024; 14(3):448-453.

PMID: 39430361 PMC: 11488802. DOI: 10.4103/tjo.TJO-D-22-00176.


Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing.

Wang X, Hong J, Xu Y, Zhang P, Li Y, Dou H BMC Ophthalmol. 2024; 24(1):99.

PMID: 38438866 PMC: 10913400. DOI: 10.1186/s12886-024-03334-8.


Uveitis masquerade syndromes: A case series.

Ganesh S, Ahmed A Oman J Ophthalmol. 2023; 15(3):353-355.

PMID: 36760922 PMC: 9905893. DOI: 10.4103/ojo.ojo_169_21.


Primary Vitreoretinal Lymphoma: A Retrospective Study of 20 Eyes.

Luo J, Yu S, Xu X, Lin X, Luo R, Long C J Ophthalmol. 2022; 2022:4522974.

PMID: 35814482 PMC: 9270130. DOI: 10.1155/2022/4522974.


Vitreoretinal lymphoma occurring after systemic chemotherapy for primary conjunctival diffuse large B cell lymphoma: A case report.

Niidome E, Usui Y, Takahashi R, Nagao T, Goto H Medicine (Baltimore). 2021; 100(39):e27347.

PMID: 34596140 PMC: 8483852. DOI: 10.1097/MD.0000000000027347.


References
1.
Lee S, Kim M, Kim J, Oh S, Kim S, Kwon Y . Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study. Blood Res. 2016; 50(4):242-7. PMC: 4705050. DOI: 10.5045/br.2015.50.4.242. View

2.
Mochizuki M, Singh A . Epidemiology and clinical features of intraocular lymphoma. Ocul Immunol Inflamm. 2009; 17(2):69-72. DOI: 10.1080/09273940902957305. View

3.
Coupland S, Damato B . Understanding intraocular lymphomas. Clin Exp Ophthalmol. 2008; 36(6):564-78. DOI: 10.1111/j.1442-9071.2008.01843.x. View

4.
Kaburaki T, Taoka K, Matsuda J, Yamashita H, Matsuda I, Tsuji H . Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma. Br J Haematol. 2017; 179(2):246-255. DOI: 10.1111/bjh.14848. View

5.
Sarraf D, Jain A, Dubovy S, Kreiger A, Fong D, Paschal J . Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Retina. 2005; 25(1):94-8. DOI: 10.1097/00006982-200501000-00018. View